CDC warns of resurgence risk and urges vaccination for Mpox

CDC warns of Mpox resurgence risk, urges high-risk individuals to get vaccinated to prevent outbreaks, emphasizing the importance of immunization.
Kavita Verma
Vaccine durability questions arise as Mpox cases increase among vaccinated individuals
Vaccine durability questions arise as Mpox cases increase among vaccinated individuals

iStock/lakshmiprasad S 

A "substantial risk" of a rebound of Mpox cases this summer has the Centres for Disease Control and Prevention (CDC) raising the alarm. To prevent the potential outbreak, authorities are advising people of high risk, such as gay, bisexual, and other individuals, to receive the entire range of vaccinations. The warning comes as a fresh cluster of cases, one of the largest outbreaks since cases sharply decreased last autumn, was found in Chicago.

Concerns regarding the longevity of vaccine immunity and whether it diminishes with time have been raised in light of the recent cluster of cases in Chicago. A sizable portion of the 21 cases discovered were among individuals who had either gotten a partial or complete immunization. 

While the vaccination may not totally prevent infection, Demetre Daskalakis, deputy director of the White House Mpox task force, observed that people who have taken two doses have a considerably lower chance of developing and transmitting the disease.

The usefulness of the Mpox vaccine in preventing the illness and lessening its severity among those who contract it was highlighted in three different studies that were released on Thursday. Daskalakis emphasized that receiving two vaccine doses is far more beneficial than just one, despite variances in approach. According to the research, vaccine effectiveness rates ranged from 66 to 88.5 percent.

Renewed prevention efforts and vaccination are crucial to avoid resurgence

To lessen the chance of a comeback, Daskalakis emphasized the necessity for continued preventative measures, particularly through vaccination. Without higher vaccination rates, he emphasized, there is a considerable chance of an outbreak. 

The United States has reported approximately 30,000 Mpox cases and 42 fatalities since May 2022. Although there have been fewer instances since the peak in August, it is still important to target high-risk groups.

Less than 25% of the 1.7 million high-risk individuals have received both doses of the Jynneos Mpox vaccine, despite the fact that over 1.2 million people have received at least one dose. The CDC's Mpox response incident manager, Christopher Braden, stressed the importance of raising vaccination rates, particularly among gay and bisexual males who are HIV-positive or taking pre-exposure prophylaxis medication to avoid HIV infection.

Call to Action: Time to get vaccinated

Daskalakis recommended people get immunized right now in light of the most recent events and the potential for a recurrence. He emphasized the significance of getting both the first and second doses, advising those who haven't had their first shot to do so and urging those who aren't yet vaccinated to finish the procedure.

Add Interesting Engineering to your Google News feed.
Add Interesting Engineering to your Google News feed.
message circleSHOW COMMENT (1)chevron
Job Board